apitegromab tirzepatide Apitegromab, a selective antimyostatin monoclonal antibody targeting muscle preservation, added to reduced muscle loss by ~55% over 24 weeks without affecting overall weight loss in the phase 2 EMBRAZE trial. https://t.co/jDqTipQrZa FDA Grants Tirzepatide a New

We understand the importance of cost-effective weight loss medications

Other drug options There are other types of prokinetic medications that are being used as attractive options for treating gastroparesis, including 5-HT receptor agonists (tegaserod and mosapride), dopamine receptor antagonists (levosulpiride), cholecystokinin receptor antagonists (dexloxiglumide), and motilin receptor agonists (mitemcinal [GM-611]

Growth hormone: May improve with weight loss, though effects are variable

GLP-1 is a naturally occurring hormone released after eating that helps regulate appetite and food intake

This keeps treatment safe, predictable, and aligned with each patients goals

Schedule regular eye check-ups to monitor and manage any changes in your vision while using semaglutide